MY126520A - A reinforced immunogen for an inactivated vaccine against infectious disease caused by the group of japanese encephalitis virus and a method for producing the same - Google Patents
A reinforced immunogen for an inactivated vaccine against infectious disease caused by the group of japanese encephalitis virus and a method for producing the sameInfo
- Publication number
- MY126520A MY126520A MYPI99002242A MYPI19992242A MY126520A MY 126520 A MY126520 A MY 126520A MY PI99002242 A MYPI99002242 A MY PI99002242A MY PI19992242 A MYPI19992242 A MY PI19992242A MY 126520 A MY126520 A MY 126520A
- Authority
- MY
- Malaysia
- Prior art keywords
- reinforced
- immunogen
- producing
- group
- same
- Prior art date
Links
- 241000710842 Japanese encephalitis virus Species 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 208000035473 Communicable disease Diseases 0.000 title 1
- 229940031551 inactivated vaccine Drugs 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 229940028617 conventional vaccine Drugs 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/06—Inactivation or attenuation by chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
- C12N2770/24163—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31976298 | 1998-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY126520A true MY126520A (en) | 2006-10-31 |
Family
ID=18113906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI99002242A MY126520A (en) | 1998-10-05 | 1999-06-03 | A reinforced immunogen for an inactivated vaccine against infectious disease caused by the group of japanese encephalitis virus and a method for producing the same |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6841374B1 (enExample) |
| EP (1) | EP1057889B1 (enExample) |
| JP (2) | JP4371343B2 (enExample) |
| KR (1) | KR20010032699A (enExample) |
| CN (2) | CN1618464A (enExample) |
| AU (1) | AU743546B2 (enExample) |
| CA (1) | CA2311336C (enExample) |
| MY (1) | MY126520A (enExample) |
| TW (1) | TWI227274B (enExample) |
| WO (1) | WO2000020565A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10144906B4 (de) * | 2001-09-12 | 2013-11-28 | Novartis Vaccines And Diagnostics Gmbh | Verfahren zur großtechnischen Herstellung von Impfstoffen |
| US7060280B2 (en) * | 2003-06-11 | 2006-06-13 | Academia Sinica | Immunization against flavivirus |
| US7780027B2 (en) * | 2007-02-08 | 2010-08-24 | Michael Coady | Axially stacked double barrel animal feeder system |
| JP5535910B2 (ja) * | 2007-08-28 | 2014-07-02 | バクスター・インターナショナル・インコーポレイテッド | ウイルスワクチンを生産する方法 |
| WO2009082002A1 (ja) | 2007-12-26 | 2009-07-02 | The Kitasato Institute | 安定に長期間保存できる日本脳炎ワクチンの製法方法及び該ワクチンの用途 |
| JP5511660B2 (ja) | 2008-06-04 | 2014-06-04 | 一般財団法人化学及血清療法研究所 | 不活化日本脳炎ウイルス粒子をアジュバントとして使用する方法 |
| CN101333246B (zh) * | 2008-07-30 | 2011-04-13 | 中国农业科学院哈尔滨兽医研究所 | 乙型脑炎病毒e蛋白中和性b细胞抗原表位多肽及其应用 |
| CA3001374A1 (en) * | 2008-11-17 | 2010-05-20 | Vgx Pharmaceuticals, Llc | Antigens that elicit immune response against flavivirus and methods of using same |
| KR20120027381A (ko) * | 2009-05-25 | 2012-03-21 | 파나세아 바이오테크 리미티드 | 일본뇌염 백신 및 그것의 제조 방법 |
| CN101792741A (zh) * | 2010-04-07 | 2010-08-04 | 西北农林科技大学 | 表达jev免疫原基因的重组杆状病毒及其制备和应用 |
| JP6963460B2 (ja) * | 2016-10-27 | 2021-11-10 | 一般財団法人阪大微生物病研究会 | たん白質の定量方法 |
| WO2021161390A1 (ja) * | 2020-02-10 | 2021-08-19 | 花王株式会社 | ヒトノロウイルス不活化評価法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6147185A (ja) * | 1984-08-09 | 1986-03-07 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスの精製方法 |
| JPS6153227A (ja) * | 1984-08-23 | 1986-03-17 | Biseibutsu Kagaku Kenkyusho:Kk | 日本脳炎・豚パルボウイルス感染症混合生ワクチン |
| AT393356B (de) * | 1989-12-22 | 1991-10-10 | Immuno Ag | Verfahren zur herstellung von fsme-virus-antigen |
| US5719051A (en) * | 1989-12-22 | 1998-02-17 | Immuno Aktiengesellschaft | Perfusion system and a method for the large scale production of virus or virus antigen |
| JPH07265093A (ja) * | 1994-03-30 | 1995-10-17 | Chemo Sero Therapeut Res Inst | 哺乳動物細胞を用いる日本脳炎ウイルス表面抗原蛋白質の製法 |
| WO1997004803A1 (fr) | 1995-08-01 | 1997-02-13 | Pasteur Merieux Serums & Vaccins | Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu |
| US6207439B1 (en) * | 1997-03-25 | 2001-03-27 | Center For Disease Control | Purification of Japanese encephalitis virus |
| US5891705A (en) | 1997-04-08 | 1999-04-06 | Pentose Pharmaceuticals, Inc. | Method for inactivating a virus |
| DE122009000037I2 (de) | 1997-08-28 | 2011-06-16 | Cheil Jedang Corp | Ein an vero-zellen angepasstes abgeschwächtes japanisches enzephalitis virus und ein impfstoff gegen japanische enzephalitis |
-
1999
- 1999-06-02 WO PCT/JP1999/002931 patent/WO2000020565A1/ja not_active Ceased
- 1999-06-02 CN CNA2004100473162A patent/CN1618464A/zh active Pending
- 1999-06-02 KR KR1020007005984A patent/KR20010032699A/ko not_active Ceased
- 1999-06-02 CA CA 2311336 patent/CA2311336C/en not_active Expired - Fee Related
- 1999-06-02 AU AU40578/99A patent/AU743546B2/en not_active Ceased
- 1999-06-02 JP JP2000574663A patent/JP4371343B2/ja not_active Expired - Lifetime
- 1999-06-02 EP EP99923858A patent/EP1057889B1/en not_active Expired - Lifetime
- 1999-06-02 US US09/555,704 patent/US6841374B1/en not_active Expired - Fee Related
- 1999-06-02 CN CNB998017647A patent/CN1160454C/zh not_active Expired - Fee Related
- 1999-06-02 TW TW88109144A patent/TWI227274B/zh not_active IP Right Cessation
- 1999-06-03 MY MYPI99002242A patent/MY126520A/en unknown
-
2009
- 2009-07-08 JP JP2009162261A patent/JP5095685B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1057889A1 (en) | 2000-12-06 |
| JP2009225809A (ja) | 2009-10-08 |
| CN1287573A (zh) | 2001-03-14 |
| CA2311336C (en) | 2007-01-02 |
| US6841374B1 (en) | 2005-01-11 |
| EP1057889B1 (en) | 2009-04-22 |
| TWI227274B (en) | 2005-02-01 |
| WO2000020565A1 (en) | 2000-04-13 |
| CN1618464A (zh) | 2005-05-25 |
| CN1160454C (zh) | 2004-08-04 |
| JP5095685B2 (ja) | 2012-12-12 |
| AU743546B2 (en) | 2002-01-31 |
| CA2311336A1 (en) | 2000-04-13 |
| KR20010032699A (ko) | 2001-04-25 |
| AU4057899A (en) | 2000-04-26 |
| JP4371343B2 (ja) | 2009-11-25 |
| EP1057889A4 (en) | 2002-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2217882A1 (en) | European vaccine strains of the porcine reproductive and respiratory syndrome virus (prrsv) | |
| LU91314I2 (fr) | "Combinaison de particules viroides de papillomavirus humain de type 6, 11, 16 et 18 (GARDASIL -GilGARD )" | |
| TW289050B (enExample) | ||
| AU4324996A (en) | Novel cyclodextrin-derivatives and methods for the preparation thereof | |
| EP0675904A4 (en) | HUMANE NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE VIRUS FROM HUMAN THAT MAKES THE IMMUNE. | |
| ZA978865B (en) | Reshaped human anti-HM 1.24 antibody. | |
| RU96119986A (ru) | Вакцина для предохранения свиньи от респираторных или репродуктивных заболеваний, содержащая парагриппозные вирусы | |
| KR930703362A (ko) | 병원체로부터 얻은 항원성 폴리오사이드로부터 유도된 올리고사이드 | |
| EA199700413A1 (ru) | Композиция, содержащая вакцину и конъюгат антигена и полисахарида, адсорбированные на фосфате алюминия | |
| RU97101084A (ru) | Штамм streptococcus equi, микробиологически чистая культура, живая вакцина и способ ее получения | |
| EP2066332A4 (en) | FLUID MIXTURE OF MANNANE AND A GRIPPE ANTIGEN | |
| GR3035135T3 (en) | Poultry vaccine containing infections bronchitis virus serotype 4/91. | |
| CA2233932A1 (en) | Vaccines against infections caused by yf virus; yf infectious cdna, method for producing a recombinant yf virus from the yf infectious cdna and plasmids to assemble the yf infectious cdna | |
| ES533111A0 (es) | Un metodo de preparar una vacuna viva | |
| IL95867A0 (enExample) | ||
| EP1013757A3 (en) | Attenuated forms of bovine viral diarrhea virus | |
| CA2311336A1 (en) | Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same | |
| HUP9801917A2 (hu) | Immunogén készítmény, eljárás annak előállítására és vakcinaként történő alkalmazására | |
| AU3830995A (en) | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines | |
| CA2116500A1 (en) | Canine coronavirus vaccine from feline enteric coronavirus | |
| CA2286399A1 (en) | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines | |
| EP0750669A4 (en) | CHANGED L2-PROTEIN OF THE PAPILLOMAVIRUS AND PRESENT VIROID | |
| IE830861L (en) | Equine influenza vaccine. | |
| AU3115189A (en) | Live combination vaccine | |
| PL346195A1 (en) | Chicken anaemia virus (cav) of weakened patogenicity, vaccine for protecting poultry against cav and method of obtaining cav of weakened pathogenicity |